|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2892535 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13835019.4 |
| Date of filing the European patent application | 2013-08-30 | |
| (97) | Date of publication of the European application | 2015-07-15 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-22 |
| (46) | Date of publication of the claims translation | 2021-12-10 |
| (86) | Number | PCT/US2013/057432 |
| Date | 2013-08-30 |
| (87) | Number | WO 2014/039375 |
| Date | 2014-03-13 |
| (30) | Number | Date | Country code |
| 201261696375 P | 2012-09-04 | US |
| (72) |
LAQUERRE, Sylvie , US
LEBOWITZ, Peter F. , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Adjuvantinis vėžio gydymo būdas |
| METHOD OF ADJUVANT CANCER TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 13 | 289.00 EUR |
| 2026-08-30 |